Copper-64: a real theranostic agent
Bianca Gutfilen,1 Sergio AL Souza,1 Gianluca Valentini2 1Department of Radiology, School of Medicine, Laboratório de Marcação de Células e Moléculas (LMCM), Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil; 2Advanced Center Oncolo...
Main Authors: | Gutfilen B, Souza SAL, Valentini G |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-10-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/copper-64-a-real-theranostic-agent-peer-reviewed-article-DDDT |
Similar Items
-
Radiobiological Characterization of <sup>64</sup>CuCl<sub>2</sub> as a Simple Tool for Prostate Cancer Theranostics
by: Joana Fernandes Guerreiro, et al.
Published: (2018-11-01) -
Biodistribution and radiation dosimetry of [64Cu]copper dichloride: first-in-human study in healthy volunteers
by: M.A. Avila-Rodriguez, et al.
Published: (2017-12-01) -
Copper-64 Chloride Exhibits Therapeutic Potential in Three-Dimensional Cellular Models of Prostate Cancer
by: Catarina I. G. Pinto, et al.
Published: (2020-12-01) -
Biological Pathways as Substantiation of the Use of Copper Radioisotopes in Cancer Theranostics
by: Dana Niculae, et al.
Published: (2021-01-01) -
Biokinetic and dosimetric aspects of 64CuCl2 in human prostate cancer: possible theranostic implications
by: Sergio Righi, et al.
Published: (2018-03-01)